Immortalized Human Primary Trabecular Meshwork Cells - SV40
| Specifications | |
|---|---|
| Cell Category: | Immortalized Cell Lines |
| Organism: | Human |
| Tissue of Origin: | Juxtacanalicular and corneoscleral regions of human eye |
| Morphology: | Polygonal |
| Culture Properties: | Adherent |
| Immortalization Method: | Serial passaging and transduction with recombinant lentiviruses carrying SV40 Large T antigen |
Propagation
Please contact us for propagation details.
Additional Information
Immortalized Human Primary Trabecular Meshwork Cells - SV40 were derived from the normal juxtacanalicular and corneoscleral tissue regions of the human eye, and were immortalized with SV40. Recommended for use in research for glaucoma and studies involving trabecular meshwork functions.
Commercial Price Disclaimer
Researchers at for-profit organizations and corporations, please contact us for pricing of this item.
Genetically Modified Organism (GVO)
See General Terms.
Product Citations
- Nakamura, H., Watanabe, M., Takada, K., Sato, T., Hikage, F., Umetsu, A., Muramatsu, J., Furuhashi, M., & Ohguro, H. (2024) Modulation of Epithelial–Mesenchymal Transition Is a Possible Underlying Mechanism for Inducing Chemoresistance in MIA PaCa-2 Cells against Gemcitabine and Paclitaxel. Biomedicines
- Watanabe, M., Sato, T., Umetsu, A., Ogawa, T., Nishikiori, N., Suzuki, M., Furuhashi, M., & Ohguro, H. (2024) The Specific ROCK2 Inhibitor KD025 Alleviates Glycolysis through Modulating STAT3-, CSTA- and S1PR3-Linked Signaling in Human Trabecular Meshwork Cells Biomedicines
- Watanabe, M., Sato, T., Yano, T., Higashide, M., Ogawa, T., Nishikiori, N., Furuhashi, M., & Ohguro, H. (2024) mTOR Inhibitors Modulate the Biological Nature of TGF-β2-Treated or -Untreated Human Trabecular Meshwork Cells in Different Manners Biomedicines
- Catalog Number
T0371-GVO-ABM - Supplier
ABM - Size
- Shipping
Dry Ice
- Price
- Please inquire
